EQT

EQT is a private equity firm headquartered in Stockholm, Sweden, with additional offices across Europe, North America, and the Asia Pacific region. Established in 1994, the firm specializes in buyouts, expansion capital, and infrastructure investments, focusing on mid-market companies in sectors such as healthcare, technology, industrials, and services. EQT employs a responsible ownership approach and an industrial growth strategy, seeking opportunities in regions with significant growth potential, including Northern and Eastern Europe, Asia, and the United States. The firm invests through various strategies, including private capital, real assets, credit, and public value, and aims to acquire controlling or co-controlling stakes in its portfolio companies, often holding investments for four to eight years. EQT Life Sciences, a notable segment of the firm, targets innovative healthcare and life sciences companies.

Harsh Agarwal

Director

Päivi Arminen

MD

Andreas Aschenbrenner

Partner

Michael Bauer

Partner, Head of Switzerland and Co-Head of EQT's Global Healthcare Sector Team

Daniela Begolo

Managing Director

Ralph Betz

Director of Credit Team

Lennart Blecher

Deputy Managing Partner

Per Georg Braathen

Industrial Advisor

Shannee Braun

Vice President

Marcus Brennecke

PARTNER and CO-HEAD OF EQT PRIVATE EQUITY ADVISORY TEAM

Carolina Brochado

Deputy Head, Advisory Team

Nicolas Brugère

Partner and Head of France

Drew Burdon

Partner

Benjamin Bygott-Webb

Managing Director

Sarah Carr

Investor Relations Manager

Jay Chae

Director, Client Relations and Capital Raising (APAC)

Brian Chang

Partner

Hans Clevers

Venture Partner

Crosby Cook

Partner

Alex Darden

Partner, President and Head of EQT Infrastructure Advisory Team Americas

Mads M. Ditlevsen

Partner & Head of EQT Partners Denmark

Tracy Duong

VP

Asís Echániz

Partner & Head of Spain

Victor Englesson

Partner

Matthias Fackler

PARTNER and HEAD OF EQT INFRASTRUCTURE ADVISORY TEAM EUROPE

David Forde

Partner

Per Franzén

Head of Private Capital and Deputy Managing Partner

Florian Funk

PARTNER

Anders Gaarud

Public Value Partner

Wolfgang Gorny

Partner, Private Equity

Simon Griffiths

PARTNER and HEAD OF PRIVATE EQUITY ASIA PACIFIC

Fabian Gröne

Partner, Head of Asia

Albert Gustafsson

PARTNER

Sean Ham

Managing Director, Client Relations and Capital Raising (APAC)

Adil Haque

Partner, Client Relations and Capital Raising (Americas)

Jerry He

PARTNER and HEAD OF CHINA, MID MARKET ASIA ADVISORY TEAM

Frank Heckes

PARTNER

Erika Henriksson

PARTNER

Bruno Holthof

Partner

Masoud Homayoun

PARTNER

Andreas Huber

Partner, Vice Chairperson Asia Pacific, Infrastructure

Morten Hummelmose

HEAD OF CLIENT RELATIONS and CAPITAL RAISING ADVISORY TEAM, PARTNER

Neha Jatar

Managing Director

Conni Jonsson

Co-Founder, Investment Advisory Professional, Chairman, Member of Nomination Committee, Member of Audit Committee & Member of Remuneration Committee

Matthew Kestenbaum

Managing Director

Jörg Kinberger

PARTNER

Harry Klagsbrun

PARTNER

Martijn Kleijwegt

Managing Partner and Founder

Thomas von Koch

Managing Partner and Chief Executive Officer

Nicolas Kollmann

Associate

Andrew Konopelski

Partner and Head of EQT Credit

Vesa Koskinen

PARTNER

Arvindh Kumar

Partner and Co-Head of Technology Sector Team

Eugene Lee

DIRECTOR

Matthew S. Levine

Partner and Head of Mid Market US

Mikael Lilius

Industrial Advisor

Benjamin Lim

VP

Eric Liu

PARTNER and CO-HEAD OF GLOBAL HEALTHCARE SECTOR TEAM

Robert Maclean

Partner, Private Equity

Paola Maleh

Partner & Head of EMEA

Carlota Sanchez Marco

Investor Relations MD

Anders Misund

Partner and Head of EQT Future Advisory Team.

Arnav Mitra

Director

Martin Mok

Partner and Head of Mid Market Asia

Joep Muijrers

Partner

Rikke Nielsen

PARTNER

Kristiaan Nieuwenburg

Partner and Head of Performance for Private Capital

Daniel Perez

PARTNER

Jannik Kruse Petersen

Partner and Head of Mid Market Europe

Anne Portwich Ph.D

Partner

Arno Poschik

Director

Robert Rackind

PARTNER

Hermann Rauch

DIRECTOR

Paul de Rome

Partner and Head of Credit Team

Joachim Rothe Ph.D

Managing Partner

Jussi Saarinen

Partner and Head of Client Relations and Capital Raising

Rosa Sammon, Darlene De La

Managing Director, Client Relations and Capital Raising (Americas)

Carlota Sanchez-Marco

Managing Director, Investor Relations

Carlos Santana

Partner

Mika Saukkonen

MD

Gordon Shaw

Partner

Christian Sinding

CEO and Managing Partner

Piyush Singhvi

MD

Georg Stadler

PARTNER

Dominik Stein

PARTNER

Anna Sundell

Partner

Angelo Syailendra

DIRECTOR

Tian Tan

VP

Erwin A. Thompson

PARTNER

Matteo Thun

MD

Peter Veldman

Advisor and EFMS Board Member

Felice Verduyn

Partner

Jan Vesely

Partner

Marcus Wallinder

Partner & Deputy Head of Client Relations and Capital Raising

Forrest Wang

MD

Ethan Waxman

Partner

Felice Verduyn-Van Weegen

Investment Associate

Frans Winarto

VP

Hjalmar Winbladh

Partner and Head of Ventures

Matthias Wittkowski

Partner

Ken Wong

PARTNER

James Yu

PARTNER

Julia Zhu

Managing Director

Fredrik Åtting

Partner

John Österlund

MD

Past deals in Ireland

Perfuze

Series A in 2022
Perfuze develops technology to treat acute ischemic stroke. The company was founded in 2018 and is based in Galway, Ireland.

LUMA Vision

Series A in 2021
OneProjects Design and Innovation Ltd. develops healthcare technologies for the treatment of cardiac arrhythmias. It offers VERAFEYE, a connected platform technology to revolutionize the treatment of AFib and cardiac arrhythmias. The company was incorporated in 2017 and is based in Dublin, Ireland.

Neurent Medical

Series B in 2021
Neurent Medical Limited develops medical device for treating rhinitis. The company offers a single-use device for ENT surgeons to treat both allergic and non-allergic rhinitis. The company was founded in 2015 and is headquartered in Galway, Ireland.

LUMA Vision

Series A in 2020
OneProjects Design and Innovation Ltd. develops healthcare technologies for the treatment of cardiac arrhythmias. It offers VERAFEYE, a connected platform technology to revolutionize the treatment of AFib and cardiac arrhythmias. The company was incorporated in 2017 and is based in Dublin, Ireland.
Atlantic Therapeutics is a medical technology company that develops pelvic floor muscle strengthening and nerve stimulation products. The company's devices focus on the treatment of all types of incontinence, sexual health dysfunctions, and other associated disorders by strengthening muscles and modulating nerves of the pelvic floor, enabling bladder patients to treat their conditions associated with pelvic floor weakness. Its products are backed by strong clinical evidence and subjected to controlled trials. It was established in Galway, Galway in 2013.

Finclude

Grant in 2018
Finclude offers financial well being services that empower EU citizens fair access to credit and expand the retail credit markets for financial institutions.

Dojo

Debt Financing in 2018
Paymentsense Limited is a financial technology company based in London, UK, specializing in payment gateway services and card processing solutions for small and medium-sized businesses in the UK and Ireland. Established in 2008, Paymentsense provides a range of products, including countertop, portable, and mobile card machines, as well as virtual payment gateways for online, phone, and mail transactions. The company serves over 60,000 businesses, enabling them to accept payments in various formats, including in-store, online, and on the move. Paymentsense is committed to facilitating seamless payment experiences for its clients through innovative technology and reliable service.

Dojo

Debt Financing in 2016
Paymentsense Limited is a financial technology company based in London, UK, specializing in payment gateway services and card processing solutions for small and medium-sized businesses in the UK and Ireland. Established in 2008, Paymentsense provides a range of products, including countertop, portable, and mobile card machines, as well as virtual payment gateways for online, phone, and mail transactions. The company serves over 60,000 businesses, enabling them to accept payments in various formats, including in-store, online, and on the move. Paymentsense is committed to facilitating seamless payment experiences for its clients through innovative technology and reliable service.

Vivasure Medical

Series C in 2016
Vivasure Medical Limited is a medical device company based in Galway, Ireland, focused on the research, development, and manufacturing of arterial and venous closure devices utilizing its proprietary PerQseal technology. The company specializes in creating polymer implants and delivery systems aimed at facilitating minimally invasive vessel closures in cardiology, interventional radiology, and vascular surgery. Its flagship product is an absorbable patch-based large-bore percutaneous closure device, specifically designed to close large arteriotomies during transcatheter procedures like transcatheter aortic valve replacement and endovascular aneurysm repair. Established in 2008, Vivasure Medical aims to enhance patient outcomes in vascular access procedures through innovative medical solutions.

Nordic Aviation Capital

Acquisition in 2015
Founded in Skive, Denmark in 1990 by Danish aviation entrepreneur Martin Møller, NAC is the world’s largest independently owned aircraft leasing company. NAC focuses mainly on the leasing of regional aircraft and currently have clients across the globe in Europe, North America, Asia, South America, Middle East, Russia, and Africa. Today, the Company has offices in the Denmark, Ireland, North America and Singapore. Additional representatives are located in London, Toulouse, and Berne. In the financial year ending 30 June 2015, NAC expects to generate a net profit in excess of USD 110 million, have an aircraft asset base of around USD 2.9 billion, net debt of USD 2.3 billion and shareholders’ equity of around USD 530 million.

Neuravi

Series B in 2015
Neuravi Limited is a medical device company based in Galway, Ireland, focused on developing clot retrieval devices to restore blood flow in patients who have experienced ischemic strokes caused by arterial blockages in the brain. The company offers the EmboTrap revascularization devices, which are designed for the treatment of acute ischemic strokes and are available in several European countries, including Belgium, Denmark, France, Germany, and Spain. Founded in 2009, Neuravi operates in the emerging neurointerventional device market and collaborates with researchers and clinicians to advance treatment solutions for this serious condition. As of April 2017, Neuravi is a subsidiary of DePuy Ireland Unlimited Company.